New study shows advance in CAR T-cell therapy eliminates severe side effects

    Source: Xinhua| 2019-04-23 18:39:02|Editor: xuxin
    Video PlayerClose

    LOS ANGELES, April 23 (Xinhua) -- An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, according to a new study of the University of Southern California (USC).

    "This is a major improvement. We've made a new CAR molecule that is just as efficient at killing cancer cells, but it works more slowly and with less toxicity," said Si-Yi Chen of the USC Norris Comprehensive Cancer Center, and senior author of the study appearing online Monday in Nature Medicine.

    This improved version of CAR T therapy produced no serious side effects in 25 patients who had lymphoma that recurred after previous treatments. Although the study was designed to look at safety, not effectiveness, six out of 11 participants receiving a commonly used dose went into complete remission.

    CAR T therapy involves harvesting immune cells called T cells from a patient's blood and then modifying them in the lab to produce special structures called chimeric antigen receptors (CAR) on their surface.

    The altered T cells are reinfused into the patient, where the cells' new receptors enable them to recognize and latch onto cancer cells, killing them.

    Approved by the U.S. Food and Drug Administration less than two years ago, CAR T is a literal lifesaver for some people with leukemia and lymphoma, bringing lasting remissions to those on the brink of death.

    The downside is that the treatment often causes severe side effects -- some of them life-threatening -- which must be managed by experienced specialists.

    In this revised version, researchers tweaked the sequence and shape of the CAR molecules. As a result, the CAR T cells kill cancer cells but produce fewer cytokines and proliferate more slowly, giving the patient's body more time to clear cytokines in the blood.

    "The improved CAR T cells proliferated and differentiated into memory cells in the patients, thus producing a potent and long-lasting anti-tumor effect without causing toxicities," Chen said.

    The research team's next step is to perform a multi-center phase II to test safety and effectiveness in a larger group of patients.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001380019091
    主站蜘蛛池模板: 最近高清中文在线字幕在线观看| 美女被艹免费视频| 天天拍拍夜夜出水| 久久成人国产精品| 正文农村老少伦小说| 国产一区二区三区小向美奈子| 2021光根影院理论片| 少妇被躁爽到高潮无码文| 五十路亲子中出在线观看| 波多野结衣有一部紧身裙女教师| 国产91精品新入口| 欧美丰满白嫩bbwbbw| 在线综合亚洲欧美网站天堂| 中文字幕中文字幕中中文| 最近中文字幕免费mv视频| 亚洲精品无码人妻无码| 美女精品永久福利在线| 国产成人精品一区二三区| 91精品国产色综合久久不卡蜜| 岳双腿间已经湿成一片视频| 久久免费视频精品| 欧美乱大交xxxx| 亚洲精品无码久久毛片| 精品国精品自拍自在线| 国产免费人成视频在线观看| 手机1024看片| 在线观看你懂得| 一边摸边吃奶边做爽动态| 日本熟妇色一本在线观看| 亚洲中文字幕久在线| 毛片让我看一下毛片| 免费看成人aa片无码视频吃奶| 色多多www视频在线观看免费| 国产成人一区二区三区电影网站| 18级成人毛片免费观看| 夜夜揉揉日日人人青青| 一级特黄a视频| 日产国产欧美视频一区精品| 九一在线完整视频免费观看| 欧美怡红院免费全部视频| 亚洲美女在线观看播放|